AGREEMENT AND PLAN OF MERGER AMONG ROCHE HOLDINGS, INC., ABINGDON ACQUISITION CORP. and IGNYTA, INC. Dated as of December 21, 2017Merger Agreement • January 2nd, 2018 • Roche Holding LTD • American depositary receipts • Delaware
Contract Type FiledJanuary 2nd, 2018 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), is made and entered into as of December 21, 2017, among Roche Holdings, Inc, a Delaware corporation (“Parent”), Abingdon Acquisition Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Purchaser”), and Ignyta, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER AMONG ROCHE HOLDINGS, INC., ABINGDON ACQUISITION CORP. and IGNYTA, INC. Dated as of December 21, 2017Merger Agreement • December 22nd, 2017 • Ignyta, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 22nd, 2017 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), is made and entered into as of December 21, 2017, among Roche Holdings, Inc, a Delaware corporation (“Parent”), Abingdon Acquisition Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Purchaser”), and Ignyta, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER among MH SUB I, LLC, DIAGNOSIS MERGER SUB, INC. and WEBMD HEALTH CORP. Dated as of July 24, 2017Merger Agreement • July 26th, 2017 • WebMD Health Corp. • Services-business services, nec • Delaware
Contract Type FiledJuly 26th, 2017 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER, dated as of July 24, 2017 (this “Agreement”), among MH Sub I, LLC, a Delaware limited liability company (“Parent”), Diagnosis Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Purchaser”), and WebMD Health Corp., a Delaware corporation (the “Company”).